Tamara A. Favorito
Independent ChairMs. Tamara A. Favorito, also known as Seymour, C.P.A., MBA, serves as Independent Director at Zevra Therapeutics, Inc. (formerly known as KemPharm, Inc.) since August 18, 2021 and serves as its Independent Chair since May 2023. She is an Independent Director at Kintara Therapeutics, Inc. since April 29, 2021. She has been Independent Director at Artelo Biosciences, Inc. since March 3, 2021. Ms. Favorito served as an Interim Chief Financial Officer of Immunic Therapeutics, Inc. since April 26, 2019 until August 2019. Ms. Favorito served as the Chief Financial Officer of Signal Genetics, Inc. since August 4, 2014 until February 2017. Since 2018, Ms. Favorito has served as a financial advisor, assisting life sciences companies with merger and acquisition activities and other finance-related needs. Ms. Favorito served the Chief Financial Officer of HemaQuest Pharmaceuticals, Inc. since December 2010 until 2014. She served as the Chief Financial Officer of Favrille Inc. (alternate name MMRGlobal, Inc.) since May 2001 until 2009 and its Vice President of Finance and Administration since February 2004. She also served as Principal Accounting Officer of Favrille Inc. From 1991 to May 2001, she served as consulting Chief Financial Officer for a number of biotechnology companies. She served as an Acting Chief Financial Officer of VitaGen, Inc. From 1988 to 1991, she served as Director of Finance with Agouron Pharmaceuticals, Inc. From 1980 to 1988 and also served as its Controller, she worked as an Accountant with Deloitte & Touche LLP and Coopers & Lybrand, Inc. (now PricewaterhouseCoopers LLP). Ms. Favorito is a corporate finance veteran with three decades of experience in the biotech and life sciences industries. She has served as Chief Financial Officer in both public and venture-backed private companies at all stages of development. Ms. Seymour?s experience includes leading finance, investor relations, managed care and reimbursement, human resources, administration and information technology. Ms. Favorito was also a member of the Board of Directors of Beacon Discovery, Inc. since September 2018 until March 2021. Ms. Favorito is a Certified Public Accountant (inactive) and received a bachelor's degree in Business Administration with an emphasis in Accounting from Valdosta State University and an M.B.A. with an emphasis in Finance from Georgia State University. Ms. Favorito also participated in an executive management program at Kellogg Graduate School of Management at Northwestern University.
公司職務
- 公司名稱Zevra Therapeutics, Inc.股票代碼ZVRA職務Independent Chair共事同僚
- NFNeil F. McFarlanePresident, CEO & Director
- TATamara A. FavoritoIndependent Chair
- RWRahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer
- JAJustin A. RenzCFO & Treasurer
- NLNichol L. OchsnerVice President of Investor Relations & Corporate Communications
- APAlison PetersChief People Officer
- BBBarney BishopChairman of Scientific and Medical Advisory Board
- JAJeffrey A. GudinCo-Chair of Physician Advisory Council
- SNSrinivas NalamachuCo-Chair of Physician Advisory Council
- 公司名稱Artelo Biosciences, Inc.股票代碼ARTL職務Independent Director共事同僚
- GDGregory D. GorgasPresident, CEO, Secretary & Director
- CLConnie L. MatsuiIndependent Chairperson of the Board
- MEMark E. SpringCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- AYAndrew YatesSenior VP & Chief Scientific Officer
- SDSteven D. ReichChief Medical Officer
- JHJason H. BaybuttSenior Vice President of Finance
- SKSteven KellyIndependent Director
- DWDouglas W. BlayneyIndependent Director
